135 related articles for article (PubMed ID: 27907860)
41. In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability.
Santos AO; Pereira JP; Pedroso de Lima MC; Simões S; Moreira JN
Braz J Med Biol Res; 2010 Oct; 43(10):1001-9. PubMed ID: 20922271
[TBL] [Abstract][Full Text] [Related]
42. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
Li J; Viallet J; Haura EB
Cancer Chemother Pharmacol; 2008 Mar; 61(3):525-34. PubMed ID: 17505826
[TBL] [Abstract][Full Text] [Related]
43. Polyionic complex of single-walled carbon nanotubes and PEG-grafted-hyperbranched polyethyleneimine (PEG-PEI-SWNT) for an improved doxorubicin loading and delivery: development and in vitro characterization.
Farvadi F; Tamaddon A; Sobhani Z; Abolmaali SS
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):855-863. PubMed ID: 27176858
[TBL] [Abstract][Full Text] [Related]
44. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
45. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
46. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
47. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
Lo YL; Liu Y
PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
[TBL] [Abstract][Full Text] [Related]
48. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer.
Lev-Ari S; Starr AN; Vexler A; Kalich-Philosoph L; Yoo HS; Kwon KR; Yadgar M; Bondar E; Bar-Shai A; Volovitz I; Schwarz Y
Food Funct; 2021 Sep; 12(17):8068-8077. PubMed ID: 34286798
[TBL] [Abstract][Full Text] [Related]
49. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
50. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
Niederst MJ; Sequist LV; Poirier JT; Mermel CH; Lockerman EL; Garcia AR; Katayama R; Costa C; Ross KN; Moran T; Howe E; Fulton LE; Mulvey HE; Bernardo LA; Mohamoud F; Miyoshi N; VanderLaan PA; Costa DB; Jänne PA; Borger DR; Ramaswamy S; Shioda T; Iafrate AJ; Getz G; Rudin CM; Mino-Kenudson M; Engelman JA
Nat Commun; 2015 Mar; 6():6377. PubMed ID: 25758528
[TBL] [Abstract][Full Text] [Related]
51. Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
Ozvaran MK; Cao XX; Miller SD; Monia BA; Hong WK; Smythe WR
Mol Cancer Ther; 2004 May; 3(5):545-50. PubMed ID: 15141012
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
[TBL] [Abstract][Full Text] [Related]
53. Adsorption and in vitro release study of curcumin form polyethyleneglycol functionalized multi walled carbon nanotube: kinetic and isotherm study.
Koupaei Malek S; Gabris MA; Hadi Jume B; Baradaran R; Aziz M; Karim KJBA; Rashidi Nodeh H
Daru; 2019 Jun; 27(1):9-20. PubMed ID: 30554368
[TBL] [Abstract][Full Text] [Related]
54. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma.
Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V
Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614
[TBL] [Abstract][Full Text] [Related]
55. Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
Dean EJ; Cummings J; Roulston A; Berger M; Ranson M; Blackhall F; Dive C
Neoplasia; 2011 Apr; 13(4):339-47. PubMed ID: 21472138
[TBL] [Abstract][Full Text] [Related]
56. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion.
Xie Z; Choong PF; Poon LF; Zhou J; Khng J; Jasinghe VJ; Palaniyandi S; Chen CS
Cancer Chemother Pharmacol; 2008 Nov; 62(6):949-57. PubMed ID: 18259754
[TBL] [Abstract][Full Text] [Related]
58. Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.
Wan X; Min Y; Bludau H; Keith A; Sheiko SS; Jordan R; Wang AZ; Sokolsky-Papkov M; Kabanov AV
ACS Nano; 2018 Mar; 12(3):2426-2439. PubMed ID: 29533606
[TBL] [Abstract][Full Text] [Related]
59. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
60. Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells.
Ohgino K; Terai H; Yasuda H; Nukaga S; Hamamoto J; Tani T; Kuroda A; Arai D; Ishioka K; Masuzawa K; Ikemura S; Kawada I; Naoki K; Fukunaga K; Soejima K
Cancer Sci; 2020 Oct; 111(10):3793-3801. PubMed ID: 32687646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
